GK
Official website
Griffin Katz
DHSc, MHA · CHFP, CRCR
Healthcare revenue-cycle executive, published health scientist, and founder and CEO of Precertif.ai, an AI platform that predicts and prevents medical claim denials. Based in San Diego, California.
- 10+ yearsin healthcare revenue cycle
- 27%denial-rate cut in six months at NYC Health + Hospitals
- 220+citations of published research
- Patent pendingPrecertif.ai denial-prediction technology
Griffin Katz at a glance
- Known for
- Founder and CEO of Precertif.ai (Precertify) · Clinical innovation · Healthcare optimization · Published researcher
- Companies
- Precertif.ai (founder and CEO) · Medformics (founder and CEO)
- Based in
- San Diego, California
- Education
- DHSc, Touro University California · MHA, NYU Robert F. Wagner Graduate School of Public Service · B.S., University of Michigan
- Certifications
- CHFP, CRCR, CSBI, and CSPR, Healthcare Financial Management Association (HFMA)
- Research ID
- ORCID 0009-0005-4153-2913 · Google Scholar
About Griffin Katz
Griffin Katz, DHSc, MHA, is a healthcare revenue-cycle executive and health scientist based in San Diego, California. He is the founder and CEO of Precertif.ai, which scores medical claims for denial risk before they are submitted and drafts regulation-backed appeal letters when denials do happen, and of Medformics, a healthcare technology company.
Griffin has spent more than a decade on the business side of medicine. At NYC Health + Hospitals, the largest municipal health system in the United States, he designed and led a system-wide denials-management initiative that reduced denial rates 27% in six months, helped recover more than $7.7 million in lost revenue, and raised billing accuracy from 87% to 98%. As a senior healthcare consultant at Guidehouse, he led revenue-cycle analytics for a $1B+ multi-system health care client and cut accounts-receivable days by 31%.
Alongside his operating work, Griffin Katz publishes peer-reviewed research, including a sole-author systematic review and meta-analysis of GLP-1 receptor agonists in Hormone and Metabolic Research (2025) and co-authorship of a Methods in Enzymology paper on imaging bone marrow fat that has been cited more than 220 times.
Griffin holds a Doctor of Health Science from Touro University California, a Master of Health Administration from NYU's Robert F. Wagner Graduate School of Public Service, and a B.S. from the University of Michigan.
Work
Founder and CEO
Precertif.ai scores every medical claim for denial risk before it is submitted and generates regulation-backed appeal letters, helping provider revenue-cycle teams stop denials before they start. The underlying technology is patent pending.
Medformics
Founder & CEO · 2023–present
A healthcare technology company building AI-driven clinical decision support and patient financial analytics tools.
Previously
- Senior Healthcare Consultant, Guidehouse. Revenue-cycle analytics for a $1B+ multi-system health care client; 31% reduction in accounts-receivable days.
- Revenue Management Analyst, NYC Health + Hospitals. Led a system-wide denials-management initiative (27% lower denial rates in six months); $7.7M+ in recovered revenue.
Areas of expertise
- Revenue cycle management
- Denial prevention & appeals
- Prior authorization
- Payer policy & medical necessity
- AI in healthcare operations
- Epic revenue-cycle workflows
- Health economics & outcomes research
- GLP-1 pharmacotherapy research